Terlipressin

Product Details
Formula	C52H74N16O15S2
Molecular Weight	1227.37
Sequence	Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge: Cys4-Cys9)
Sequence Shortening	GGGCYFQNCPKG-NH2 (Disulfide bridge: Cys4-Cys9)
Smiles String	O=C([[email protected]](CSSC[[email protected]@H](C(N[[email protected]](C1=O)CC2=CC=C(O)C=C2)=O)NC(CNC(CNC(CN)=O)=O)=O)NC([[email protected]@H](NC([[email protected]@H](NC([[email protected]](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[[email protected]@H]4C(N[[email protected]@H](CCCCN)C(NCC(N)=O)=O)=O

Storage & Handling
Shipping	Room temperature.
Storage	Please refer to the instruction manual.

Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

! For research use only. Not intended for any clinical use.